Impact of Palifermin on Transplant Outcomes in Children and Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation.
Krzysztof CzyŻewskiRobert DĘbskiNatalia BartoszewiczEwa DemidowiczMonika Richert-PrzygoŃskaMonika ŁĘckaSonia TarasenkoJan StyczyŃskiPublished in: Anticancer research (2020)
Palifermin had no impact on transplant outcomes in children and adolescents undergoing allo-HCT.